Artificial Intelligence, Clinical Insights & Research, Technology

AI Identifies Previously Unrecognized Health Insights in Routine Sleep Studies

A novel AI model can use information collected during routine sleep studies to identify patients’ long-term health risks, according to a new study published in Nature Communications. Developed by a multidisciplinary research team, the model uncovered hidden sleep patterns linked to risks including heart disease, cognitive decline and death. The […]

Narcolepsy, Pharmacological, Sleep Disorders

FDA Approves Takeda’s Orzeyful, the First-Ever Orexin Agonist for Narcolepsy Type 1

The U.S. Food and Drug Administration today approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults. Orzeyful is the first medicine approved for narcolepsy type 1 as a complete disorder — addressing the full range of symptoms that define the condition — and the first to […]

Artificial Intelligence, Clinical Insights & Research, Technology

New Study Uses Sleep Monitoring and AI to Detect Alzheimer’s

Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa in Leganés, part of the public health network of the Comunidad de Madrid, have developed a methodology that uses artificial intelligence (AI) to analyze brain electrical activity during sleep and facilitate the early diagnosis of Alzheimer’s. The […]

Patient Advocacy & Awareness, Sleep Disorders

Bridging the Communication Gap in Sleep Medicine

In sleep medicine, a profound communication barrier persists: the patient’s lived experience is often lost in translation. While clinicians use precise terms like polysomnogram, patients hear a “sleep study” — or worse, they dismiss lifelong, devastating exhaustion as simply “normal.” In a world where words like tired, fatigued, and sleepy […]